News | Cardio-oncology | June 15, 2017

New Echo Protocol Aids Monitoring Children’s Heart Abnormalities Due to Chemotherapy

Pediatric echo protocols for cardio-oncology cardiotoxicity exams.

 June 15, 2017 – Children who have suffered from cancer may also have lasting side effects from the drugs used in the treatment of cancer, or chemotherapy-induced cardiotoxicity. The use of anthracyclines, very effective chemotherapy drugs, can be limited by development of cardiotoxicity, which has been traditionally monitored by echocardiography. A recent study at Children’s Hospital of Michigan used real-time 3-D imaging to detect early functional abnormalities associated with cardiotoxicity in the hearts of children following anthracycline chemotherapy.

“In our research study, we evaluated heart function of children who had completed anthracycline chemotherapy for cancer using a real-time 3-D echocardiography technique,” said lead author Sanjeev Aggarwal, M.D., pediatric cardiologist at The Children's Hospital of Michigan and Wayne State University School of Medicine, Detroit, Mich. “We found that, an average of five years after chemotherapy, asymptomatic children who had normal volume of the ventricles of the heart and normal ejection fraction, still had significant left ventricular dyssynchrony on the 3D echo. Dyssynchrony is a difference in contraction timing of various heart segments. The ability of this noninvasive bedside technique to diagnose cardiac dysfunction in the subclinical stage, even before abnormalities can be detected on a conventional echo, may open the possibilities of timely intervention and prevention of progression of the cardiotoxicity. Currently, when cardiotoxicity is detected, it can be irreversible. Further longitudinal studies are needed.” 
 
Researchers on the study, Left Ventricular Dyssynchrony and Real Time 3-D Echocardiogram in Children Following Chemotherapy include Sanjeev Aggarwal, M.D., and Gilda Kadiu, RDCS from Children's Hospital of Michigan.
 
Aggarwal presented a poster based on this research during the recent ASE 28th Annual Scientific Sessions. 

Watch the VIDEO "Assessing Cardiotoxicity Response With Cardio-Oncology Echo Imaging."  This is an interview with Federico Asch, M.D., FACC, FASE, associate director of the echocardiography core lab at Medstar Health Research Institute and assistant professor of medicine (cardiology) at Georgetown University, at the American Society of Echocardiography (ASE) 2016 annual meeting. Asch discusses the technology used for cardio-oncology cardiotoxcity assessments and how to set up these types of collaborative programs between oncology and cardiology. For more information, read the article Assessing Cardiotoxicity Due to Cancer Therapy.

Read the related article “Assessing Cardiotoxicity Due to Cancer Therapy.” 

For more information: ASEcho.org
 


Related Content

News | Cardio-oncology

June 19, 2024 — Modern therapies have extended the lives of many cancer patients; however, survivors often live with ...

Home June 19, 2024
Home
News | Cardio-oncology

February 1, 2023 — The International Cardio-Oncology Society has awarded University Hospitals (UH) Harrington Heart & ...

Home February 01, 2023
Home
News | Cardio-oncology

May 23, 2022 — New data from a study of more than 100 million hospitalizations using machine learning augmentation was ...

Home May 23, 2022
Home
News | Cardio-oncology

February 25, 2020 — Results of a multi-centre, international, clinical trial co-led by Peter Munk Cardiac Centre (PMCC) ...

Home February 25, 2021
Home
News | Cardio-oncology

July 29, 2019 — Cancer patients taking cholesterol-lowering statin medication following radiation therapy of the chest ...

Home July 29, 2019
Home
Videos | Cardio-oncology

Magid Awadalla, MBBS, is an advanced cardiac imaging research fellow at Massachusetts General Hospital. He has been ...

Home March 22, 2019
Home
News | Cardio-oncology

March 13, 2019 — An imaging procedure commonly performed before starting cancer treatment can provide valuable clues ...

Home March 13, 2019
Home
News | Cardio-oncology

January 28, 2019 — The American College of Cardiology host the third Advancing the Cardiovascular Care of the Oncology ...

Home January 28, 2019
Home
News | Cardio-oncology

January 3, 2019 — Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage ...

Home January 03, 2019
Home
News | Cardio-oncology

December 21, 2018 — Older adults with cancer are more likely to have had a heart attack or stroke in the months prior to ...

Home December 21, 2018
Home
Subscribe Now